Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 2568-2571, October 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janoff, A.
Right arrow Articles by Troll, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janoff, A.
Right arrow Articles by Troll, W.

Local Vascular Changes Induced by the Cocarcinogen, Phorbol Myristate Acetate1

A. Janoff, A. Klassen and W. Troll

Departments of Pathology and Environmental Medicine, New York University School of Medicine, New York, New York 10016

One µg of phorbol myristate acetate, an active tumor-promoting agent from croton oil, produces a severe, local vascular reaction in skin (ear) of CF1 and STS mice. The response is characterized by hyperemia and edema formation which can be quantitatively monitored by measuring uptake of circulating 125I-labeled bovine serum albumin. Microscopic detection of sites of endothelial injury in mice receiving i.v. carbon suspension shows the reaction to be primarily limited to venules. These microvascular changes are accompanied by mast cell degranulation in the affected tissues. Reactions develop about 1 hr after phorbol ester application, persist through 6 to 8 hr, and appear to be lessening in intensity by 24 hr. High doses (50 µg) of 7,12-dimethylbenz(a)anthracene induce similar vascular changes, although of much lower intensity and after a longer delay interval. Antagonists of histamine, serotonin, and kinins produce mild, transient suppression of the local vascular response to the phorbol ester. Hydrocortisone and salicylate are without effect on this component of the tissue reaction. Local application of tosyl phenylalanine chloromethyl ketone, a protease inhibitor previously shown to suppress tumor promotion, affords a more sustained protection against the inflammatory activity of the phorbol ester.

1 The work reported herein was supported in part by USPHS Research Grants HE 08192 and K3-GM-6461 and American Cancer Society Research Grant IN-14K.

Received 4/ 1/70. Accepted 6/16/70.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
D. C. Liebler and J. A. Burr
Effects of UV light and tumor promoters on endogenous vitamin E status in mouse skin
Carcinogenesis, February 1, 2000; 21(2): 221 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.